Point Of Care Hematology Diagnostics Market Report 2026

Point Of Care Hematology Diagnostics Market Overview

• Point Of Care Hematology Diagnostics market size has reached to $2.9 billion in 2025 • Expected to grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Increasing Prevalence Of Blood Disorders Fueling The Growth Of The Market Due To Rising Chronic Disease Incidence And Need For Timely Monitoring • Market Trend: Artificial Intelligence-Powered Cartridge System Transforms On-Site Blood Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the point of care hematology diagnostics market include: • Prescription Based Product (Segmentation By Mode Of Prescription) → Expected gain of $992.7 Million • Complete Blood Count (Segmentation By Type) → Expected gain of $529.1 Million • Diagnostic Centers (Segmentation By End User) → Expected gain of $520.3 Million

What Is Covered Under Point Of Care Hematology Diagnostics Market?

Point of care hematology diagnostics refers to medical tests conducted at or near the site of patient care to quickly assess blood-related conditions, such as anemia, infections, or clotting disorders. These tests provide rapid, accurate hematological results to support timely clinical decisions, especially in emergency or resource-limited settings. This approach reduces the need for centralized laboratory testing and accelerates diagnosis and treatment. The main types of point-of-care hematology diagnostics are complete blood count, coagulation testing, hemoglobin testing, anemia diagnosis, and others. A complete blood count (CBC) is a blood test that measures various components of blood, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelets, to help evaluate overall health and detect a wide range of disorders. These diagnostics are available in products as consumables and systems. The different modes of prescription include both prescription-based and over-the-counter-based products, catering to various end users such as diagnostic centers, hospitals, blood banks, transfusion centers, and others.

What Is The Point Of Care Hematology Diagnostics Market Growth Forecast?

The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising prevalence of chronic and infectious diseases, expansion of point of care testing programs, increasing demand for rapid diagnostics in emergency care, technological advancements in compact hematology analyzers, growth in decentralized healthcare delivery models. Major trends in the forecast period include rising adoption of rapid bedside blood testing, growing demand for decentralized diagnostics in emergency settings, increasing use of portable and handheld hematology devices, expansion of point of care testing in resource-limited areas, focus on faster turnaround time for clinical decision-making.

What Is The Driver Of The Point Of Care Hematology Diagnostics Market?

The increasing prevalence of blood disorders is expected to propel the growth of the point-of-care hematology diagnostics market going forward. Blood disorders refer to conditions that affect the components of blood, including red blood cells, white blood cells, platelets, or plasma. The increasing incidence of blood disorders is primarily due to the rising prevalence of chronic diseases, which directly impact blood health and require ongoing monitoring. Point-of-care hematology diagnostics help in the timely detection and monitoring of blood disorders by providing rapid, accurate results at or near the site of patient care, enabling quicker clinical decisions and improved disease management.For instance, in November 2024, according to the The American Society of Hematology a US-based Non-profit organization, projected that global leukemia cases could increase to approximately 519,540 by 2050. Therefore, the rising incidence of blood disorders is driving the growth of the point-of-care hematology diagnostics market.

How Will The Drivers Impact Growth In The Global Point Of Care Hematology Diagnostics Market?

• Rising Geriatric Population (High) – The rising geriatric population will become a key driver of growth in the point of care hematology diagnostics market by 2030. The increasing elderly population significantly boosts demand for rapid blood testing because older individuals are more prone to conditions like anemia, infections, and blood cancers. Frequent monitoring becomes essential for managing chronic illnesses such as cardiovascular and metabolic disorders. This creates strong reliance on fast, bedside blood analysis tools that reduce hospital visits. Aging populations also require continuous health tracking in outpatient and home-care settings. Studies show that this demographic shift is a key structural growth factor for decentralized diagnostic solutions. As a result, the rising geriatric population is anticipated to contributing to a 2.0% annual growth in the market. • Expansion Of Private Diagnostic Centers And Clinic Chains (Medium) – The expansion of private diagnostic centers and clinic chains will emerge as a major factor driving the expansion of the point of care hematology diagnostics market by 2030. The rapid growth of organized diagnostic chains and private clinics is improving access to advanced hematology testing services. These centers increasingly adopt compact analyzers to deliver faster results and reduce turnaround time compared to centralized labs. Rising outpatient volumes and preventive health checkups are further increasing testing frequency. Standardization and investment in automation also encourage adoption of modern diagnostic equipment. This expansion strengthens the infrastructure needed for faster and more accessible blood testing services. Consequently, the expansion of private diagnostic centers and clinic chains is projected to contributing to a 1.5% annual growth in the market. • Increasing Use Of Point Of Care Diagnostics In Rural And Remote Healthcare Settings (Medium) – The increasing use of point of care diagnostics in rural and remote healthcare settings will serve as a key growth catalyst for the point of care hematology diagnostics market by 2030. In rural and underserved regions, limited laboratory infrastructure creates demand for portable and easy-to-use blood testing systems. These tools help overcome delays in diagnosis by enabling immediate testing at primary health centers. They are especially important where access to centralized labs is restricted by distance or logistics. Point-of-care systems improve early disease detection and treatment initiation in such areas. Their deployment is widely recognized as a solution for bridging healthcare gaps in resource-limited settings. Therefore, this increasing use of point of care diagnostics in rural and remote healthcare settings is projected to supporting to a 1.0% annual growth in the market. • Increasing Demand For Cost-Effective Diagnostic Tools (Low) – The increasing demand for cost-effective diagnostic tools will become a significant driver contributing to the growth of the point of care hematology diagnostics market by 2030. Healthcare systems are increasingly shifting toward affordable and rapid diagnostic solutions to reduce overall treatment costs. Compact hematology analyzers lower expenses by reducing lab dependency and hospital admissions. They also minimize repeat testing and shorten diagnostic timelines, improving efficiency. In cost-sensitive regions, affordability is a major factor driving adoption of simpler blood testing devices. However, balancing low cost with accuracy remains a key focus in technology development. Consequently, the increasing demand for cost-effective diagnostic tools is projected to contributing to a 0.5% annual growth in the market.

How Will The Restraints Impact Growth In The Global Point Of Care Hematology Diagnostics Market?

• Regulatory Challenges (High) – Regulatory challenges is expected to restrain market growth during the forecast period. It creates operational, financial, regulatory, or commercial challenges that can increase costs, delay projects, reduce investments, or discourage purchasing decisions depending on the market. These challenges can reduce product adoption, affect business confidence, and limit the ability of companies to expand efficiently across key regions. This can reduce operational efficiency, delay expansion plans, and affect the ability of companies to achieve sustainable business growth. • Connectivity Issues (Medium) – During the forecast period, connectivity issues is likely to limit market expansion. It creates operational, financial, regulatory, or commercial challenges that can increase costs, delay projects, reduce investments, or discourage purchasing decisions depending on the market. These challenges can reduce product adoption, affect business confidence, and limit the ability of companies to expand efficiently across key regions. As a result, businesses may face increased cost pressures, slower commercial adoption, and reduced revenue opportunities. • Impact Of Trade Wars And Tariffs (Medium) – The market is expected to face challenges due to impact of trade wars and tariffs over the forecast period. It creates operational, financial, regulatory, or commercial challenges that can increase costs, delay projects, reduce investments, or discourage purchasing decisions depending on the market. These challenges can reduce product adoption, affect business confidence, and limit the ability of companies to expand efficiently across key regions. This may discourage new investments, delay strategic expansion initiatives, and weaken the overall competitive position of market participants.

Key Players In The Global Point Of Care Hematology Diagnostics Market

Major companies operating in the point of care hematology diagnostics market are F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio‑Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio‑Rad Laboratories Inc.

Global Point Of Care Hematology Diagnostics Market Trends and Insights

Major companies operating in the point-of-care hematology diagnostics market are focusing on developing technologically advanced products, such as cartridge-based AI-powered hematology analyzers, to deliver rapid, accurate, and on-site blood analysis for improved patient care. Cartridge-based AI-powered hematology analyzers are compact diagnostic devices that use single-use reagent cartridges and artificial intelligence algorithms to quickly and accurately analyze blood samples at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer designed for veterinary use. This innovative system delivers rapid, reference laboratory-quality complete blood count (CBC) results within minutes at the point of care, while reducing maintenance and hands-on time. It is equipped with advanced AI-driven image analysis and viscoelastic focusing technology that precisely aligns cells for clear imaging, enabling accurate blood cell classification and automated abnormality detection, thereby ensuring efficient and reliable veterinary diagnostics.

What Are Latest Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market?

In June 2023, Mars Inc., a US-based pet company, acquired Heska Corporation for an undisclosed amount. With this acquisition, Mars Inc. aims to expand its veterinary diagnostics capabilities and strengthen its position in advanced animal healthcare through Heska’s innovative diagnostic and specialty solutions. Heska Corporation is a US-based veterinary diagnostics company offering point-of-care (POC) hematology diagnostics.

What Defines the Point Of Care Hematology Diagnostics Market?

The point of care hematology diagnostics market consists of revenues earned by entities by providing services such as rapid blood testing, decentralized diagnostic solutions, and home-based blood monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care hematology diagnostics market also includes sales of portable hematology analyzers, cartridges and test kits, lancets, and reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Point Of Care Hematology Diagnostics Market Report 2026?

The point of care hematology diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point of care hematology diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.